Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Financial
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Financial
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Financial
BioSpace Movers & Shakers, Oct. 30
Financial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Financial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Financial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Financial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Financial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Financial
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Commercial
Financial
Financial
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Financial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide Corporate Update on Tuesday, November 10, 2020
Biospace News
-
November 10, 2020
Financial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on November 5, 2020 Nasdaq:OYST
Financial
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Thursday, November 5, 2020
Financial
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord Pharma
Financial
FTC nod clears way for merger between Pfizer’s Upjohn unit, Mylan – FirstWord Pharma
Financial
X-37, LLC Appoints David Gluckman, M.D., to Board of Directors
Biospace News
-
October 30, 2020
0
Financial
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November...
Biospace News
-
October 30, 2020
0
Financial
Epizyme Announces Date of Third Quarter 2020 Financial Results
Biospace News
-
October 30, 2020
0
Financial
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the...
Globenewswire News
-
October 30, 2020
0
Financial
Euro-Australian collaboration offers scalable solutions for biotech: announced at Bio-Europe 2020
Globenewswire News
-
October 30, 2020
0
1
2
3
...
216
Page 1 of 216
- Advertisement -
MOST POPULAR
Initial probe clears Chinese Alzheimer’s drug developer of academic fraud ...
December 1, 2019
Takeda Receives Approval of Entyvio (Vedolizumab) in China for the Treatment...
February 20, 2019
Recipharm notes an increased demand for Chloroquine Phosphate
March 6, 2020
Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the...
November 15, 2019
Load more
HOT NEWS
Others
ValiRx progresses VAL301 Clinical Development Plan
Clinical
Dr. Reddy’s Laboratories announces launch of Doxercalciferol Injection in the U.S....
Phase I
Merrimack Discontinues Development of MM-310
Financial
Mallinckrodt’s shares hit as US court upholds CMS decision on Acthar...
